Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review.
Moss CL, Guerrero-Urbano T, White I, Taylor B, Kristeleit R, Montes A, Fox L, Beyer K, Sztankay M, Ratti MM, Sisca ES, Derevianko A, MacLennan S, Wood N, Wintner LM, Van Hemelrijck M. Moss CL, et al. Among authors: guerrero urbano t. Future Oncol. 2023 Mar;19(9):663-678. doi: 10.2217/fon-2022-0111. Epub 2023 May 2. Future Oncol. 2023. PMID: 37128990 Review.
ATR gene mutations in HPV negative oropharyngeal cancer.
Jeannon JP, Tanaka A, Thavaraj S, Guerrero-Urbano T, McGrath JA, Tavassoli M. Jeannon JP, et al. Oral Oncol. 2017 Feb;65:121-123. doi: 10.1016/j.oraloncology.2016.12.009. Epub 2016 Dec 23. Oral Oncol. 2017. PMID: 28017652 No abstract available.
Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
Paleri V, Patterson J, Rousseau N, Moloney E, Craig D, Tzelis D, Wilkinson N, Franks J, Hynes AM, Heaven B, Hamilton D, Guerrero-Urbano T, Donnelly R, Barclay S, Rapley T, Stocken D. Paleri V, et al. Health Technol Assess. 2018 Apr;22(16):1-144. doi: 10.3310/hta22160. Health Technol Assess. 2018. PMID: 29650060 Free PMC article. Clinical Trial.
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
James ND, Sydes MR, Clarke NW, Mason MD, Dearnaley DP, Spears MR, Ritchie AW, Parker CC, Russell JM, Attard G, de Bono J, Cross W, Jones RJ, Thalmann G, Amos C, Matheson D, Millman R, Alzouebi M, Beesley S, Birtle AJ, Brock S, Cathomas R, Chakraborti P, Chowdhury S, Cook A, Elliott T, Gale J, Gibbs S, Graham JD, Hetherington J, Hughes R, Laing R, McKinna F, McLaren DB, O'Sullivan JM, Parikh O, Peedell C, Protheroe A, Robinson AJ, Srihari N, Srinivasan R, Staffurth J, Sundar S, Tolan S, Tsang D, Wagstaff J, Parmar MK; STAMPEDE investigators. James ND, et al. Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
In Regard to Reber et al.
Humbert-Vidan L, Patel V, King AP, Guerrero Urbano T. Humbert-Vidan L, et al. Among authors: guerrero urbano t. Adv Radiat Oncol. 2023 Jul 14;8(4):101222. doi: 10.1016/j.adro.2023.101222. eCollection 2023 Jul-Aug. Adv Radiat Oncol. 2023. PMID: 37465003 Free PMC article. No abstract available.
54 results